Literature DB >> 9152572

The use of claims databases for outcomes research: rationale, challenges, and strategies.

B R Motheral1, K A Fairman.   

Abstract

Health care payers and policy makers need information about the cost and effectiveness of medical treatments. While randomized controlled trials historically are the primary source of medical information, they are expensive and labor-intensive, and often have limited utility for answering questions about "real-world" patient populations. These problems have led to an increasing reliance on claims database research in making policy decisions about treatment options. However, both researchers and decision makers should recognize the limitations and unique features of claims databases. Recommendations for avoiding or minimizing threats to internal validity, construct validity, and external validity are: (1) use of a study design that includes comparisons; (2) ensuring that the study design and conclusions are consistent with the database; (3) a priori conceptual modeling of the research question; (4) use of appropriate constructs; (5) explicit examination of alternative explanations for study findings; (6) sensitivity analyses of key assumptions; (7) awareness of the distinction between statistical and practical significance of findings; (8) generalization only when appropriate; and (9) reporting of relevant information. Given that any study design or data source has limitations, we hope that this paper will encourage a philosophy of methodological pluralism in outcomes research. Awareness and accurate reporting of validity issues will strengthen and extend the information resources currently available to decision makers.

Entities:  

Mesh:

Year:  1997        PMID: 9152572     DOI: 10.1016/s0149-2918(97)80122-1

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  40 in total

1.  Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population.

Authors:  L T Piecoro; M Potoski; J C Talbert; D E Doherty
Journal:  Health Serv Res       Date:  2001-06       Impact factor: 3.402

Review 2.  Methods for claims-based pharmacoeconomic studies in psychosis.

Authors:  Frank Gianfrancesco; Ruey-Hua Wang; Ramy Mahmoud; Richard White
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 3.  Assessing the use of retrospective databases in conducting economic evaluations of drugs: the case of asthma.

Authors:  Fredrik Berggren
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

4.  Role of observational studies in assessing osteoporosis therapies: the REAL study.

Authors:  Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

5.  Psychological Research With Administrative Data Sets: An Underutilized Strategy for Mental Health Services Research.

Authors:  James T Walkup; Philip T Yanos
Journal:  Prof Psychol Res Pr       Date:  2005-10

6.  The effect of complementary and alternative medicine claims on risk adjustment.

Authors:  Bonnie K Lind; Chad Abrams; William E Lafferty; Paula K Diehr; David E Grembowski
Journal:  Med Care       Date:  2006-12       Impact factor: 2.983

Review 7.  The role of observational studies in optimizing the clinical management of chronic myeloid leukemia.

Authors:  Michael J Mauro; Catherine Davis; Teresa Zyczynski; H Jean Khoury
Journal:  Ther Adv Hematol       Date:  2015-02

8.  Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women.

Authors:  V Rabenda; R Mertens; V Fabri; J Vanoverloop; F Sumkay; C Vannecke; A Deswaef; G A Verpooten; J Y Reginster
Journal:  Osteoporos Int       Date:  2008-06       Impact factor: 4.507

9.  Anxiety disorders and rapid cycling: data from a cohort of 8129 youths with bipolar disorder.

Authors:  Ruby Castilla-Puentes; Regina Sala; Bernardo Ng; Juan Galvez; Alvaro Camacho
Journal:  J Nerv Ment Dis       Date:  2013-12       Impact factor: 2.254

Review 10.  Osteoporosis therapies: evidence from health-care databases and observational population studies.

Authors:  Stuart L Silverman
Journal:  Calcif Tissue Int       Date:  2010-08-20       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.